John C Byrd Selected Research

John C Byrd Research Topics

Disease

226	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2022 - 02/2002
172	Neoplasms (Cancer) 01/2022 - 02/2002
61	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2004
50	Leukemia 11/2021 - 02/2002
32	Lymphoma (Lymphomas) 01/2021 - 04/2003
22	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 02/2002
21	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021 - 01/2009
20	Disease Progression 01/2022 - 01/2002
18	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 09/2003
15	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 04/2007
14	Tumor Lysis Syndrome 10/2020 - 08/2003
13	Infections 11/2021 - 04/2002
13	Multiple Myeloma 01/2019 - 05/2008
11	Chromosome Aberrations (Chromosome Abnormalities) 01/2022 - 01/2003
11	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021 - 08/2003
10	Diarrhea 01/2021 - 07/2010
9	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2020 - 04/2008
8	Atrial Fibrillation 11/2021 - 03/2015
8	Hemorrhage 01/2021 - 01/2015
8	Fatigue 12/2019 - 09/2011
8	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2013
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2014 - 05/2005
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2021 - 03/2009
7	Neutropenia 01/2020 - 07/2010
7	Lymphocytosis 01/2020 - 09/2006
7	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2016 - 04/2008
6	Hypertension (High Blood Pressure) 01/2022 - 12/2018
6	Lymphadenopathy 11/2019 - 09/2006
5	Nausea 12/2019 - 01/2003
5	Residual Neoplasm 12/2016 - 03/2004
5	Thrombocytopenia (Thrombopenia) 01/2015 - 04/2005
4	B-Cell Leukemia (Leukemia, B Cell) 01/2021 - 10/2007
4	Cytopenia 01/2020 - 02/2014
4	Lymphoid Leukemia 04/2017 - 01/2004
4	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2016 - 04/2005
4	Agammaglobulinemia (Hypogammaglobulinemia) 01/2016 - 04/2002
4	Fever (Fevers) 07/2014 - 09/2002
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2013 - 02/2004

Drug/Important Bio-Agent (IBA)

82	ibrutinibIBA 11/2022 - 06/2011
42	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022 - 06/2011
42	Rituximab (Mabthera)FDA Link 01/2020 - 02/2002
36	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2003
28	alvocidib (flavopiridol)IBA 06/2016 - 06/2005
27	fludarabineIBA 05/2015 - 02/2002
22	Pharmaceutical PreparationsIBA 01/2021 - 04/2005
19	Biological ProductsIBA 01/2020 - 01/2002
18	Lenalidomide (CC 5013)FDA Link 12/2020 - 05/2008
17	acalabrutinibIBA 01/2022 - 01/2016
16	Monoclonal AntibodiesIBA 01/2020 - 02/2002
12	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 12/2005
11	MicroRNAs (MicroRNA)IBA 01/2018 - 06/2009
11	Histones (Histone)IBA 01/2016 - 07/2003
10	Decitabine FDA Link 01/2020 - 07/2005
10	Cyclin-Dependent Kinases (cdk Proteins)IBA 04/2016 - 01/2007
10	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 02/2005
9	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2020 - 01/2003
9	Phosphotransferases (Kinase)IBA 01/2020 - 05/2005
9	Bortezomib (Velcade)FDA Link 01/2020 - 09/2006
9	Immunoglobulins (Immunoglobulin)IBA 04/2016 - 02/2004
9	Fingolimod Hydrochloride (FTY720)FDA Link 09/2015 - 09/2007
8	AntibodiesIBA 10/2022 - 08/2007
8	venetoclaxIBA 12/2021 - 10/2018
8	idelalisibIBA 11/2019 - 09/2010
8	CytokinesIBA 01/2019 - 02/2011
8	Pentostatin (Nipent)FDA LinkGeneric 01/2015 - 04/2005
8	Alemtuzumab (Campath)FDA Link 12/2013 - 07/2003
7	obinutuzumabIBA 01/2022 - 01/2016
7	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 11/2021 - 08/2004
7	AntigensIBA 12/2016 - 03/2004
7	Interleukin-2 (IL2)IBA 12/2016 - 09/2004
6	RNA (Ribonucleic Acid)IBA 10/2020 - 06/2009
6	interleukin-21 (interleukin 21)IBA 01/2020 - 05/2008
6	Imatinib Mesylate (Gleevec)FDA Link 12/2014 - 05/2005
5	OSU-2SIBA 01/2022 - 06/2011
5	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 07/2003
5	Biomarkers (Surrogate Marker)IBA 01/2019 - 12/2007
5	ofatumumab FDA Link 12/2018 - 03/2013
5	Histone Deacetylase InhibitorsIBA 10/2017 - 01/2004
5	Messenger RNA (mRNA)IBA 04/2017 - 08/2007
5	milatuzumabIBA 06/2015 - 04/2011
5	MethyltransferasesIBA 06/2009 - 02/2005
4	Chlorambucil (Leukeran)FDA Link 01/2022 - 05/2006
4	Long Noncoding RNAIBA 01/2022 - 12/2014
4	EnzymesIBA 01/2021 - 04/2004
4	mouse MIRN29 microRNAIBA 01/2019 - 06/2009
4	Immunoglobulin G (IgG)IBA 04/2016 - 02/2004
4	OligodeoxyribonucleotidesIBA 06/2015 - 04/2008
4	Antisense OligonucleotidesIBA 06/2015 - 01/2003
4	OligonucleotidesIBA 01/2013 - 06/2009
4	NF-kappa B (NF-kB)IBA 07/2010 - 02/2008
4	Complement System Proteins (Complement)IBA 01/2008 - 02/2002
4	CaspasesIBA 03/2005 - 02/2002
3	Chimeric Antigen ReceptorsIBA 11/2022 - 03/2016
3	selinexorIBA 01/2022 - 05/2015

Therapy/Procedure

145	Therapeutics 10/2022 - 04/2002
35	Drug Therapy (Chemotherapy) 01/2022 - 02/2002
6	Immunotherapy 01/2022 - 09/2004
5	Aftercare (After-Treatment) 01/2019 - 02/2002
5	Renal Dialysis (Hemodialysis) 05/2015 - 11/2007
4	Stem Cell Transplantation 01/2020 - 01/2006